Allyson Li

Allyson Li works on intellectual property matters involving biotechnological, pharmaceutical, chemical and medical device inventions.

While Allyson pursued her doctorate in chemistry at Columbia University, her research included developing a high-throughput platform to profile the sequence specificity of tyrosine kinases, an important class of signaling proteins involved in cancer. She also served as a visiting scientist at the University of Cambridge’s Cancer Research UK Cambridge Institute.